Systematic Review and Meta-Analysis of Global Vaccination Coverage

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".

Deadline for manuscript submissions: closed (31 January 2021) | Viewed by 2377

Special Issue Editor


E-Mail Website
Guest Editor
1. Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC 3800, Australia
2. Honorary Fellow, School of Veterinary Science, Faculty of Science, The University of Queensland, Brisbane, QLD 4072, Australia
Interests: biostatistics; Bayesian statistics; sample size; asymptotic properties; animal research
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Enhancing vaccination coverage is the mainstay of preventing unwanted morbidities and mortalities from vaccine-preventable diseases. The current universal health coverage (UHC) paradigm emphasizes equity and low financial hardship in getting the health services that all people and communities need. According to the WHO, an estimated 19.4 million children under the age of one year did not receive basic vaccines. In this Special Issue, we would like to summarize vaccination coverage and combinations of vaccines against diseases that have an international public health impact and appraise the resulting decline in vaccine-preventable diseases burden and related health gains. Hence, this Special Issue will assess the global status quo with regard to vaccination coverage and successes in the prevention and control of vaccine-preventable diseases. This Special Issue will explore the unmet needs for vaccination coverage by various segments of the population including children and women.

Dr. Solomon Woldeyohannes 
Guest Editor

Keywords

  • Vaccination coverage rates
  • Cost benefits of vaccination
  • Rate of vaccine-preventable burden
  • Universal health coverage

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:
8 pages, 562 KiB  
Article
Monitoring of Influenza Vaccination Coverage among Pregnant Women in Germany Based on Nationwide Outpatient Claims Data: Findings for Seasons 2014/15 to 2019/20
by Annika Steffen, Thorsten Rieck and Anette Siedler
Vaccines 2021, 9(5), 485; https://doi.org/10.3390/vaccines9050485 - 11 May 2021
Cited by 2 | Viewed by 1843
Abstract
Pregnant women and their infants are at increased risk for severe influenza-related complications. A decade has passed since influenza vaccination was first recommended for pregnant women in Germany in 2010; however, monitoring of vaccination coverage (VC) has not yet been implemented for this [...] Read more.
Pregnant women and their infants are at increased risk for severe influenza-related complications. A decade has passed since influenza vaccination was first recommended for pregnant women in Germany in 2010; however, monitoring of vaccination coverage (VC) has not yet been implemented for this target group. Using nationwide outpatient claims data, we here provide results on influenza VC among pregnant women in Germany for seasons 2014/15 to 2019/20. For any given season, pregnant women were defined as women who had undergone prenatal health care in at least two consecutive quarters within a season. VC increased from 9.0% in season 2014/15 to 16.6% in 2019/20 (+84%), while most of the increase occurred from season 2016/17 (VC: 9.9%) onwards (+68%). Consistently across seasons, women in east Germany were 40 to 60% more likely to be vaccinated compared to women residing in west Germany. According to age, the highest VC was observed among women aged 35 to <40 years (2019/20: 18.2%). Despite noticeable increases in influenza VC during recent years, overall coverage remains low among pregnant women. Starting with this analysis, VC among pregnant women in Germany will be monitored on a yearly basis in order to detect trends and identify immunization gaps. Full article
(This article belongs to the Special Issue Systematic Review and Meta-Analysis of Global Vaccination Coverage)
Show Figures

Figure 1

Back to TopTop